Advertisement

Clinical Research in Cardiology

, Volume 106, Issue 6, pp 411–419 | Cite as

Trends in aortic valve replacement in Germany in 2015: transcatheter versus isolated surgical aortic valve repair

  • Luise Gaede
  • Johannes Blumenstein
  • Won-Keun Kim
  • Christoph Liebetrau
  • Oliver Dörr
  • Holger Nef
  • Christian Hamm
  • Albrecht Elsässer
  • Helge Möllmann
Original Paper

Abstract

Aims

We analysed the number of procedures, indications, and in-hospital mortality rates of all patients undergoing isolated surgical aortic valve replacement (sAVR) or transvascular (TV-) and transapical (TA-) transcatheter aortic valve implantation (TAVI) from 2012 to 2015 in Germany.

Methods and results

More than 31,000 aortic valve procedures were performed in 2015 in Germany, representing a total increase of 4.5% over 2014. TV-TAVI accounts for 13,108 of these procedures, with an increase of 21%, whereas the numbers of isolated sAVR and TA-TAVI decreased slightly. Age, frailty, high risk, and patients’ choice were the main reasons for a catheter-based intervention. In 2015, the in-hospital mortality rate after TV-TAVI decreased to 3.4%, approaching that of sAVR (2.9%), despite a considerably higher baseline risk. A stratified analysis according to the German aortic valve (AKL) score demonstrated a further decrease of the in-hospital mortality for TV-TAVI, showing a lower in-hospital mortality rate than expected in all risk groups. Importantly, this also accounts for the lowest risk group with an AKL score <3% showing an in-hospital mortality rate of 1.7%, which is now comparable to that of sAVR (1.5%). In all other risk groups, the in-hospital mortality in patients undergoing TV-TAVI was lower than in patients undergoing sAVR.

Conclusions

Mortality after TV-TAVI keeps decreasing over the last years and equals that of SAVR in the lowest risk cohort in the meanwhile. All TV-TAVI patients have significantly lower observed than expected mortality, which will further lead to a redefinition of standard of care.

Keywords

TAVI Aortic valve replacement Outcome Mortality Logistic EuroScore AKL score 

Notes

Acknowledgements

We thank Elizabeth Martinson, Ph.D., of the KHFI Editorial Office for her editorial assistance. We also thank Emilie Hofstetter for her assistance in analysing the data.

Compliance with ethical standards

Conflict of interest

Helge Möllmann received speaker honoraria and/or travel grants from Edwards Lifesciences, St. Jude Medical, Symetis SA. Luise Gaede and Johannes Blumenstein received travel grants from Edwards Lifesciences, St. Jude Medical, Symetis SA. Won Keun Kim is a proctor for St. Jude Medical and Symetis SA.

References

  1. 1.
    Lefèvre T, Kappetein AP, Wolner E et al (2011) One year follow-up of the multi-centre European PARTNER transcatheter heart valve study. Eur Heart J 32:148–157. doi: 10.1093/eurheartj/ehq427 CrossRefPubMedGoogle Scholar
  2. 2.
    Smith C, Leon M, Mack M, Miller D, Moses J, Svnesson L, Tuzcu E, Webb J, Fontana G, Makkar R, Williams M, Dewey T, Kapadia S, Babaliaros V, Thourani V, Corso P, Pichard A, Bavaria J, Herrmann H, Akin J, Anderson W, Wang DPS, for the PTI (2011) Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med 364:2187–2198CrossRefPubMedGoogle Scholar
  3. 3.
    Hamm CW, Möllmann H, Holzhey D et al (2014) The German Aortic Valve Registry (GARY): in-hospital outcome. Eur Heart J 35:1588–1598. doi: 10.1093/eurheartj/eht381 CrossRefPubMedGoogle Scholar
  4. 4.
    Gaede L, Kim W-K, Blumenstein J et al (2016) Temporal trends in transcatheter and surgical aortic valve replacement. Herz. doi: 10.1007/s00059-016-4461-1 PubMedGoogle Scholar
  5. 5.
    Adams DH, Popma JJ, Reardon MJ (2014) Transcatheter aortic-valve replacement with a self-expanding prosthesis. N Engl J Med 371:967–968. doi: 10.1056/NEJMc1408396 CrossRefPubMedGoogle Scholar
  6. 6.
    Möllmann H, Bestehorn K, Bestehorn M et al (2016) In-hospital outcome of transcatheter vs. surgical aortic valve replacement in patients with aortic valve stenosis—complete dataset of patients treated in 2013 in Germany. Clin Res Cardiol 105(6):553–559. doi: 10.1007/s00392-016-0962-4
  7. 7.
    Thyregod HGH, Steinbrüchel DA, Ihlemann N et al (2015) Transcatheter versus surgical aortic valve replacement in patients with severe aortic valve stenosis: one-year results from the all-comers nordic aortic valve intervention (NOTION) randomized clinical trial. J Am Coll Cardiol. doi: 10.1016/j.jacc.2015.03.014 Google Scholar
  8. 8.
    Leon MB, Smith CR, Mack MJ et al (2016) Transcatheter or surgical aortic-valve replacement in intermediate-risk patients. N Engl J Med 374:1609–1620. doi: 10.1056/NEJMoa1514616 CrossRefPubMedGoogle Scholar
  9. 9.
    Thourani VH, Kodali S, Makkar RR et al (2016) Transcatheter aortic valve replacement versus surgical valve replacement in intermediate-risk patients: a propensity score analysis. Lancet 387:2218–2225. doi: 10.1016/S0140-6736(16)30073-3 CrossRefPubMedGoogle Scholar
  10. 10.
    Kapadia SR, Leon MB, Makkar RR et al (2015) 5-year outcomes of transcatheter aortic valve replacement compared with standard treatment for patients with inoperable aortic stenosis (PARTNER 1): a randomised controlled trial. Lancet 385:2485–2491. doi: 10.1016/S0140-6736(15)60290-2 Google Scholar
  11. 11.
    Mack MJ, Leon MB, Smith CR et al (2015) 5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial. Lancet 385:2477–2484. doi: 10.1016/S0140-6736(15)60308-7 Google Scholar
  12. 12.
    Vahanian A, Alfieri O, Andreotti F et al (2012) Guidelines on the management of valvular heart disease (version 2012): the Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 33:2451–2496. doi: 10.1093/eurheartj/ehs109 CrossRefPubMedGoogle Scholar
  13. 13.
    Kuck K-H, Eggebrecht H, Elsässer A et al (2016) Qualitätskriterien zur Durchführung der kathetergestützten Aortenklappenimplantation (TAVI). Der Kardiol 10:282–300. doi: 10.1007/s12181-016-0082-4 CrossRefGoogle Scholar
  14. 14.
    Eggebrecht H, Mehta RH, Ccb B, Clinical D (2015) Transcatheter aortic valve implantation (TAVI) in Germany 2008–2014: on its way to standard therapy for aortic valve stenosis in the elderly? EuroIntervention 11:1029–1033. doi: 10.4244/EIJY15M09-11 CrossRefGoogle Scholar
  15. 15.
  16. 16.
    Parolari A, Pesce LL, Trezzi M et al (2010) EuroSCORE performance in valve surgery: a meta-analysis. Ann Thorac Surg 89(787–793):e2. doi: 10.1016/j.athoracsur.2009.11.032 Google Scholar
  17. 17.
    Kötting J, Schiller W, Beckmann A et al (2013) German aortic valve score: a new scoring system for prediction of mortality related to aortic valve procedures in adults. Eur J Cardiothorac Surg 43:971–977. doi: 10.1093/ejcts/ezt114 CrossRefPubMedGoogle Scholar
  18. 18.
    Gummert J, Funkat A, Osswald B et al (2009) EuroScore overestimates the risk of cardiac surgery: results from the national registry of the German Society of Thoracic and Cardiovascular Surgery. Clin Res Cardiol 98:363–369. doi: 10.1017/CBO9781107415324.004 CrossRefPubMedGoogle Scholar
  19. 19.
    Nilsson J, Algotsson L, Höglund P et al (2006) Comparison of 19 pre-operative risk stratification models in open-heart surgery. Eur Heart J 27:867–874. doi: 10.1017/CBO9781107415324.004 CrossRefPubMedGoogle Scholar
  20. 20.
    Durand E, Borz B, Godin M et al (2013) Performance analysis of EuroSCORE II compared to the original logistic EuroSCORE and STS scores for predicting 30-day mortality after transcatheter aortic valve replacement. Am J Cardiol 111:891–897. doi: 10.1016/j.amjcard.2012.11.056 CrossRefPubMedGoogle Scholar
  21. 21.
    Gaede L, Bartolomeo R, Kley F Van Der et al (2016) Aortic valve stenosis: what do people know? A heart valve disease awareness survey of over 8,800 people aged 60 or over. EuroIntervention 12:883–889. doi: 10.4244/EIJY16M06_02
  22. 22.
    Walther T, Hamm CW, Schuler G et al (2015) Peri-operative results and complications in 15,964 transcatheter aortic valve implantations from the German Aortic valve RegistrY (GARY). J Am Coll Cardiol. doi: 10.1016/j.jacc.2015.03.034 PubMedGoogle Scholar
  23. 23.
    Gaede L, Möllmann H (2015) Transcatheter aortic valve implantation (TAVI): current perspectives. Herz 54:742–751. doi: 10.1007/s00108-013-3382-9 CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2017

Authors and Affiliations

  • Luise Gaede
    • 1
  • Johannes Blumenstein
    • 1
  • Won-Keun Kim
    • 2
  • Christoph Liebetrau
    • 2
  • Oliver Dörr
    • 3
  • Holger Nef
    • 3
  • Christian Hamm
    • 2
    • 3
  • Albrecht Elsässer
    • 4
  • Helge Möllmann
    • 1
  1. 1.Department of Internal MedicineSt. Johannes-HospitalDortmundGermany
  2. 2.Department of CardiologyKerckhoff Heart and Thorax CenterBad NauheimGermany
  3. 3.Department of Cardiology and Angiology, Medical Clinic IUniversity of GiessenGiessenGermany
  4. 4.Department of CardiologyKlinikum OldenburgOldenburgGermany

Personalised recommendations